Kerry Giedd, Od, Ms, Faao

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Allergan is now part of AbbVie. AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn for future updates.

As a leader in eye health and part of Johnson & Johnson MedTech, we are driven by a bold ambition: Vision Made Possible™— paving the way for a new future of eye health to support the full spectrum of pediatric, adult and aging eyes. Our priority is to deliver on the eye health needs of more than 44 million patients around the world every year. Poor eye health has reached epidemic proportions and access to care around the world remains inequitable and disconnected – and we believe that we have the opportunity—and responsibility—to do more. Sight is a key component in the way many of us experience the world, learn and remember, and what many fear losing the most. We are driven to reimagine and deliver the most all-encompassing eyecare to meet the unique needs of every patient. Understanding that eye health needs change over a lifetime—from contacts to cataracts, we have built a unified, global organization that collaborates, innovates, and works seamlessly together to care for patients at every stage in their eye health journey. Through cutting-edge innovation, scientific expertise, and advanced technologies, we stand as a trusted partner, making dependable outcomes possible for our customers and patients.

We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries.

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Allergan is now part of AbbVie. AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn for future updates.

As a leader in eye health and part of Johnson & Johnson MedTech, we are driven by a bold ambition: Vision Made Possible™— paving the way for a new future of eye health to support the full spectrum of pediatric, adult and aging eyes. Our priority is to deliver on the eye health needs of more than 44 million patients around the world every year. Poor eye health has reached epidemic proportions and access to care around the world remains inequitable and disconnected – and we believe that we have the opportunity—and responsibility—to do more. Sight is a key component in the way many of us experience the world, learn and remember, and what many fear losing the most. We are driven to reimagine and deliver the most all-encompassing eyecare to meet the unique needs of every patient. Understanding that eye health needs change over a lifetime—from contacts to cataracts, we have built a unified, global organization that collaborates, innovates, and works seamlessly together to care for patients at every stage in their eye health journey. Through cutting-edge innovation, scientific expertise, and advanced technologies, we stand as a trusted partner, making dependable outcomes possible for our customers and patients.

We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries.

Eola Eyes, Downtown Orlando’s premier eye care practice, relocated to 519 North Mills Avenue in January 2011. This space represents a merger of new, progressive, state-of-the-art technology with the comfortable, warm, personal technique the practice has been known for since its inception. Dr. Brighid Williams and Dr. Kerry Giedd originally opened Eola Eyes in a historic Thornton Park house-turned-office in 2003. The new Mills Avenue office is approximately 4,300 square feet and has allowed the doctors, including Dr. Nicole Beedle, who joined the practice in 2009, to significantly increase their capacity for patient care and parking compared to the previous practice location. Eola Eyes is now complete with advanced digital technologies and expanded facilities including five exam rooms, high-tech imaging and testing equipment, and a more extensive selection of designer frames. Dr. Williams, Dr. Giedd, and Dr. Beedle provide innovative eye care and premium optical products in their optical boutique, while maintaining the urban style and comfort their patients have come to expect.